Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel peptide and use thereof

一种组合物、药学的技术，应用在治疗和/或预防软骨损伤或关节炎的新型肽领域，能够解决不容易获得足够数量的自体细胞等问题

Active Publication Date: 2013-01-23
ENSOL BIOSCI
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unfortunately, chondrocyte implantation still has a large number of problems to be solved, such as not easy to obtain a sufficient number of autologous cells, and the technical and cost issues of applying it to a large number of patients, such as the attachment of implanted cells, regenerative efficiency and safety sex

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel peptide and use thereof
  • Novel peptide and use thereof
  • Novel peptide and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] [Example 1] Preparation of peptide

[0072] At the request of the present inventors, a peptide having the amino acid sequence shown in SEQ ID NO. 1 (Glu-Leu-His-Leu-Asp) was prepared by Peptron Corporation (South Korea). Specifically, using an automated peptide synthesizer (ASP48S, Peptron Inc.), the amino acid units were linked one by one from the C-terminus by Fmoc SPPS (9-fluorenylmethoxycarbonyl solid-phase peptide synthesis method).

[0073] Use NH 2-His(Trt)-2-chloro-trityl resin, the first amino acid at the C-terminus of the peptide was attached to the resin. All amino acids used to synthesize peptides are protected by trityl (Trt), tert-butoxycarbonyl (Boc), tert-butyl (t-Bu), etc., where the N-terminus is protected by Fmoc, and all amino acids are removed in acid Residues. Using 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) / hydroxybenzotriazole (HOBT) / N-methylmorphine phenoline (NMM) as the coupling reagent. (1) Dissolve th...

Embodiment 2-12

[0074] [Example 2-12] Preparation of Peptides

[0075] The peptides of Examples 2-12 were prepared in the same manner as in Example 1, except that the amino acid sequences listed in Table 1 below were used instead of the amino acid sequences in Example 1.

[0076] Table 1

[0077] Example serial number

Embodiment 13

[0078] [Example 13] Confirmation of cartilage regeneration effect with damaged cartilage tissue explants

[0079] Articular cartilage explants were prepared from hoof joints of cows younger than 3 years old within one hour of slaughter at a regional slaughterhouse (located in Ojeong-dong, Daejeon, South Korea). For this purpose, the cartilage part other than the bone was evenly excised from the joint using a scalpel, and cut into a size of about 3 mm x 3 mm to prepare cartilage tissue explants. Using a syringe (21G) with a truncated and ground tip, the lesion area was prepared by uniformly making vertical holes in the surface of the center of the explant.

[0080] The perforated tissue explants were divided into 4 groups including the control group. Each group was placed in Dulbecco's modified Eagle's medium / F12 (DMEM / F12, 1:1, Welgene) supplemented with ascorbate (50 μg / ml, Sigma) and 10% fetal bovine serum (FBS, Invitrogen). ); then treated with 25 μM of the peptide of Exa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a peptide represented by formula (I) of X1-Leu-X2-Leu-X3 wherein X1 represents Glu or Asp, X2 represents His, Lys or Arg, X3 represents Asp or Glu, with Glu, Asp, Leu, His, Lys and Arg being respectively glutamic acid, aspartic acid, leucine, histidine, lysine and arginine; or a pharmaceutically acceptable salt thereof; a composition for the treatment or prevention of at least one selected from cartilage damage and arthritis, containing the same peptide or a pharmaceutically acceptable salt thereof as an active ingredient; and a composition containing the same peptide or a pharmaceutically acceptable salt thereof and TGFss1.; The above-mentioned peptide or a pharmaceutically acceptable salt thereof is effective for the treatment and / or prevention of cartilage damage and / or arthritis and is capable of exhibiting effects of the regeneration of cartilage tissue, the inhibition of the expression of cartilage tissue matrix degrading enzyme and / or the inhibition of cartilage tissue ossification.

Description

technical field [0001] The present invention relates to a novel peptide. In particular, the present invention relates to a novel peptide effective for the treatment and / or prevention of cartilage damage or arthritis. Background technique [0002] Cartilage tissue is composed of matrix and chondrocytes. Among them, the collagen fibers (collagen, proteoglycan) of the matrix as well as non-collagen proteins play an important role in maintaining the unique physical properties of cartilage by drawing water into or out of the cartilage. Cartilage tissue damage is often accompanied by joint diseases, and the cartilage tissue of the joint can be roughly divided into four regions, namely, the outermost superficial tangential zone (STZ), the middle zone, the deep zone, and the calcified zone (Clouet J et al., Drug Discovery Today (2009) 14:19 / 20, 913-925). The superficial tangential zone is an area with a relatively low proportion of matrix, where collagen fibers are densely arrang...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06A61P19/00A61K38/08
CPCC07K7/06A61K38/00A61K38/1841A61K38/08A61P19/00A61P19/02A61P43/00A61K2300/00A61P19/08
Inventor 金海镇李济旭权永准文银贞
Owner ENSOL BIOSCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com